STAT3 and hepatocellular carcinoma: In this study, we found that α-MGT significantly suppresses STAT3 signaling by inhibiting degradation of Src homology region 2 domain-containing phosphatase-1 (SHP1) protein, a negative regulator of STAT3 signaling, and thereby exerts a potent anti-HCC effect.